Skip to main content
Updated:
Original:

Boston Scientific profits take 3rd quarter dive

Dwindling demand for pacemakers and defibrillators cut into Boston Scientific’s bottom line in the latest quarter. Profits fell 25 percent. The company announced layoffs earlier this year for some of the Twin Cities 5,000 Boston Scientific workers.
Author:

Dwindling demand for pacemakers and defibrillators cut into Boston Scientific’s bottom line in the latest quarter. Profits fell 25 percent. The company announced layoffs earlier this year for some of the Twin Cities 5,000 Boston Scientific workers.

Next Up

unsplash medical marijuana

Edibles coming to Minnesota's medical marijuana program

MDH also announced it will not add anxiety as qualifying condition.

plow, snowplow, snow

Plowable snow possible this weekend in Minnesota

Up to half a foot of snow could fall within the heaviest band.

Best Buy - jjbers, Flickr

Police reveal new details about 'coordinated' Best Buy thefts

A large group stole thousands of dollars in merchandise from three Twin Cities Best Buy stores.

Seven Points exterior - 2

New tenant revealed for former Libertine spot in Uptown

The space will combine playful art offerings with a restaurant.

white Christmas

What are Minnesota's chances of a white Christmas this year?

The Twin Cities averages a white Christmas about 3 out of every 4 years.

ilhan omar press conference voicemail screengrab 11.30.21

'You will not live much longer b***': Rep. Omar shares threatening voicemail

Omar's office received the call hours after Rep. Boebert posted her video about the MN congresswoman.

Screen Shot 2021-12-01 at 11.24.09 AM

ESPN's 'Booger' makes fun of Wild fans' record cup snake

He's the same guy who thought the "Minneapolis Miracle" was bad for the Vikings.

brian ingram

Woodfired Cantina closes at Keg and Case in St. Paul

Restaurateur Brian Ingram is focusing on growing his other concepts.

giant bear

Video: 'THE fattest bear we have ever seen' spotted on MN trail camera

"This might be THE fattest bear we have ever seen in our area," researchers said.

u.s. attorney

Guilty plea from man who stockpiled guns, equipment to make bombs, drugs

Prosecutors say he had multiple guns, items to make weapons and pipe bombs, and lab equipment to make drugs.

Related

Boston Scientific names next CEO

Boston Scientific has selected Johnson & Johnson executive Michael Mahoney as its new chief executive. Mahoney will replace retiring CEO Ray Elliott on Nov. 1.

Boston Scientific acquires Plymouth-based BridgePoint

Massachusetts-based Boston Scientific is buying medical startup BridgePoint Medical Inc., the Star Tribune reports. The small privately held firm has developed an innovative system to clear coronary arteries without bypass surgery. Terms of the deal were not disclosed.

Boston Scientific chief earns nearly $12 million in less than three months

Michael Mahoney--Boston Scientific's future CEO--pulled in $11.78 million dollars in just 76 days on the job. Most of the compensation comes in the form of stock awards.

St. Jude Medical says third quarter profits fell 22 percent

St. Jude Medical, Inc. reported a 22 percent drop in profits for the third quarter, MarketWatch reports. The Little Canada-based medical equipment supplier and manufacturer posted a profit of $176 million, down from $227 million a year ago.

Capella Education's net profit plummets 49 percent in third-quarter

Capella Education, the parent company of the for-profit Capella University, says its third-quarter net income was $5.1 million, down nearly 50 percent compared to the $9.9 million it earned in the July-September quarter last year, the Associated Press reports. Even as total enrollment, revenue and net income fell, new student enrollment at the Minneapolis-based provider of online post-secondary education rose 10.5 percent compared to last year -- the first increase in nearly two years, Reuters reports.

TCF's profits plunge in fourth quarter

CEO Bill Cooper says new rules that cap how much banks can charge retailers for debit card transactions are partly to blame for the poor numbers. He also cited start-up costs associated with a new specialty finance division.